AmniSure logo  Educational Webinars
Webinar lab Visby Medical sponsors continuing medical educational events for healthcare professionals across the country. You can register for upcoming sessions here, or watch archived webinar recordings at any time, from anywhere. These Visby sponsored events are presented by key opinion leaders in the world of healthcare and research, and managed by Whitehat Communications to ensure a professional environment. All programs are free, and offer P.A.C.E.® Continuing Education Credits for up to six months after the live event. Be sure to check back often for new event postings. 
   

Don’t Get Tricked by Trichomonas: A Neglected Sexually Transmitted Infection
Live Event: Thursday, February 24, 2022 | 12:00 PM ET
PACE® Credit available until August 24, 2022  |  Florida Lab Credit available
  
Register
   
Trichomoniasis is the most common non-viral sexually transmitted infection, with an estimated 2.6 million infections annually. Yet it has long been neglected by clinicians and the general public as it is not a reportable disease and there are no established screening, surveillance, or control programs for women or men in the U.S. Trichomoniasis is associated with multiple adverse health outcomes in women, including adverse birth outcomes, increased risk of HIV acquisition and transmission, cervical cancer, pelvic inflammatory disease, and infertility. It is commonly under-diagnosed as the poorly sensitive wet mount of vaginal fluid has traditionally been used as the most common diagnostic test in women.

Due to the challenges of traditional Trichomonas diagnostic methods, women with this infection may be undertreated. This can lead to adverse health outcomes, inability to initiate expedited partner treatment, and persistence of the infection in sexual networks. In addition to providing updates on epidemiology, clinical relevance, and treatment recommendations, this webinar examines the diagnostic challenges associated with Trichomoniasis and evaluates a modern approach to outsmart this neglected STI.


This webinar will:
  • Review Trichomoniasis epidemiology – US and worldwide
  • Examine adverse health outcomes for women
  • Examine Trichomonas diagnosis and the associated challenges
  • Review issues surrounding drug resistance
  •   Review patient management including the 2021 CDC guidelines for Trichomonas testing & treatment
  • Evaluate a modern approach to outsmart Trichomonas
Presenter:
Christina Muzny, MD, MSPH, FACP, FIDSA
Assoc. Prof. of Medicine, Obstetrics/Gynecology, and Epidemiology
Vice Chair, UAB Institutional Review Board
Department of Medicine | Division of Infectious Diseases
Heersink School of Medicine | University of Alabama at Birmingham
Christina Muzny Photo
Dr. Christina Muzny obtained her medical degree at the Texas A&M University Health Sciences Center College of Medicine. She subsequently completed an internal medicine residency and an infectious diseases fellowship at the University of Mississippi Medical Center prior to joining the infectious diseases faculty at the University of Alabama at Birmingham (UAB) in 2010. She has since obtained a Masters of Science in Public Health (Epidemiology) at the UAB School of Public Health.
Improving Antimicrobial Stewardship in Sexually Transmitted Infections
Live Event: Wednesday, December 8, 2021 | 11:00 AM ET
PACE® Credit available until June 8, 2022  |  Florida Lab Credit available
  
Recording button   Slides button
   

Traditional molecular PCR testing requires a large analyzer in a central laboratory, supplied with reagents or cartridges and operated by skilled lab professionals. For highly accurate and reliable diagnostic results, the healthcare professional has had only two choices:

      • Send the collected patient sample to a central/remote PCR lab for batch processing, with turnaround time from hours to days, or
     • Invest in point-of-care instrumentation that can bring the test closer, but with instrument bottlenecks, downtime and ongoing expenses for maintenance, calibration and cartridges.

This problem means patients may not get the treatment or the right treatment - which often leads to unnecessary use of antibiotics and antimicrobial resistance, expedited partner treatment cannot be initiated, and patients are often lost to follow-up. When patients leave without the right treatment, the infection continues to spread in them and possibly to their partner(s) and throughout the community.

This webinar will present the 2021 CDC STI guidelines, dive into the challenges with traditional STI testing and the impact on antibiotic stewardship and review what is needed to combat the growing number of antibiotic resistant STI.

This webinar will:

  • Review 2021 CDC STI Guidelines
  • Examine key challenges with STI testing today at clinical settings such as Urgent Care and Emergency Dept / Hospital including patients lost to follow up, implications of overtreatment / undertreatment of STI
  • Evaluate the implications of today’s STI testing to Antibiotic Stewardship
  • Review STI point of care testing to combat the growing number of antibiotic resistant sexually transmitted infections  


Presenter:
Glenn Harnett, MD, FCUCM, CEO
No Resistance Consulting Group
Glenn Harnett Photo
Dr. Harnett has over 20 years of experience as a "boots on the ground" clinician, spending 10 years practicing emergency medicine before establishing himself as a nationally respected urgent care physician and key opinion leader. After five years as the Chief Medical Officer for American Family Care while they grew from 17 to 185 clinics, he founded No Resistance Consulting Group in 2016 which focuses on clinical trial site management and recruitment for a growing network of high volume, geographically diverse, urgent care, and multi-specialty trial sites. Dr. Harnett has been an active author and researcher - designing trials, writing trial protocols, and acting as a principal investigator for numerous clinical trials conducted in the urgent care setting.
Advances in PCR for POCT to Address the Sexually Transmitted Infection Epidemic
Live Event: Tuesday, October 5, 2021
PACE® Credit available until April 5, 2022  |  Florida Lab Credit available
 
Recording button   Slides button
   
The most recent CDC report on STI surveillance showed that rates of chlamydia and gonorrhea in the US were at a 20-year high in 2019 for the sixth consecutive year. STIs affect everyone. Untreated STIs cost our society billions of dollars a year yet are largely preventable. Traditional STI testing doesn’t provide an accurate result soon enough for a results-driven diagnosis during the patient visit, so clinicians prescribe STI treatments before they have a clear diagnosis. This can lead to delayed or ineffective treatment for the patient, and to the emergence of antibiotic resistant microbes.

Adopting rapid PCR at the POC would enable clinicians to have a productive discussion with the patient during the visit to help increase treatment adherence and also to reduce the number of patients who are often lost to follow-up when they leave without the right treatment. This can reduce the spread of infection in patients, their partner(s) and stop transmission throughout the community.

This webinar will present recent advances in nucleic acid amplification testing (NAAT) methodology, and instrument-free single-use PCR (polymerase chain reaction) in particular, that provides both accuracy and speed of results at the point of care. Such advancements for STI enables clinicians to make results-driven diagnoses for correct treatment, all while the patient is still at the clinic visit, for a more focused clinician-patient dialogue and ‘teachable moment’.

This webinar will:
  • Review the rising rates of Sexually Transmitted Infections (STI)
  • Analyze today’s STI testing methods
  • Discuss the challenges and implications of today’s testing methods for the patient, clinician, and public health
  • Examine the criteria for POC testing that could improve patient and clinician satisfaction scores and positively impact STI rates 
Presenter:
Gary Schoolnik, MD
Professor of Medicine, Stanford University
Chief Medical Officer, Visby Medical

Gary Schoolnik photo
Dr. Schoolnik received his M.D. degree and infectious diseases subspecialty training at the University of Washington in Seattle, served as medical intern, resident and chief resident at Harvard’s Massachusetts General Hospital in Boston and he was a research associate and associate physician at the Rockefeller University in Manhattan. While on the Stanford Medical School faculty he served as Chief of the Division of Infectious Diseases and Geographic Medicine. National service included his appointment to the Advisory Council of the National Institutes of Allergy and Infectious Diseases of the NIH and his role as chair of the NIH Trans-Institute Committee on the Human Microbiome and co-chair of the NIH Blue Ribbon Committee on Bioterrorism.
These webinars are sponsored by  AmniSure logo
 
© 2021 | Whitehat Communications, a division of Martek Inc.